Control of acute hypertension and cardiotoxicity in patients treated with vascular targeting agents
US7358236B1 · kind B1 · utility
4Cited by
6References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 23, 2003 |
| Grant date | Apr 15, 2008 |
| Priority date | — |
| Expiry date | Nov 19, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/66
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a method of using anti-hypertensive agents (“AHAs”) to attenuate the transient increase in blood pressure observed in patients where Vascular Targeting Agents (“VTAs”) are administered to treat diseases associated with malignant neovascularization. The invention also relates to pharmaceutical compositions comprising AHAs and VTAs, and to kits thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.